Daniel Mukadi-Bamuleka

Prof. Dr. Daniel Mukadi-Bamuleka

Virology, INRB, Kinshasa, Democratic Republic of the Congo
+1
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EVEmmanuel Hasivirwe Vakaniaki
Emmanuel Hasivirwe Vakaniaki
CKCris Kacita
Cris Kacita
ELEddy Kinganda - Lusamaki
Eddy Kinganda - Lusamaki
ÁOÁine O’tOole
Áine O’tOole
TWTony Wawina-Bokalanga
Tony Wawina-Bokalanga
PMPlacide Kingebeni Mbala
Placide Kingebeni Mbala
Outbreaks of monkeypox (mpox) have historically resulted from zoonotic spillover of clade I monkeypox virus (MPXV) in Central Africa and clade II MPXV in West Africa. In 2022, subclade IIb caused a global epidemic linked to transmission through sexual contact. Here we describe the epidemiological and genomic features of an mpox outbreak in a mining region in eastern Democratic Republic of the Congo, caused by clade I MPXV. Surveillance data collected between September 2023 and January 2024 identified 241 suspected cases. Genomic analysis demonstrates a distinct clade I lineage divergent from previously circulating strains in the Democratic Republic of the Congo. Of the 108 polymerase chain reaction-confirmed mpox cases, the median age of individuals was 22 years, 51.9% were female and 29% were sex workers, suggesting a potential role for sexual transmission. The predominance of APOBEC3-type mutations and the estimated emergence time around mid-September 2023 imply recent sustained human-to-human transmission.

23 October 2024 in Nature Medicine
Verified
Journal Article
Open access
PDF file
JOJames R. Otieno
James R. Otieno
CRChristopher Ruis
Christopher Ruis
AOAnyebe Bernard Onoja
Anyebe Bernard Onoja
KKKrutika Kuppalli
Krutika Kuppalli
AHAna Hoxha
Ana Hoxha
LSLorenzo Subissi
Lorenzo Subissi
Monkeypox virus (MPXV) is endemic in western and Central Africa, and in May 2022, a clade IIb lineage (B.1) caused a global outbreak outside Africa, resulting in its detection in 116 countries and territories. To understand the global phylogenetics of MPXV, we analyzed all available MPXV sequences, including 10,670 sequences from 65 countries collected between 1958 and 2024. Our analysis reveals high mobility of clade I viruses within Central Africa, sustained human-to-human transmission of clade IIb lineage A viruses within the Eastern Mediterranean region and distinct mutational signatures that can distinguish sustained human-to-human from animal-to-animal transmission. Moreover, distinct clade I sequences from Sudan suggest local MPXV circulation in areas of eastern Africa over the past four decades. Our study underscores the importance of genomic surveillance in tracking spatiotemporal dynamics of MXPV clades and the need to strengthen such surveillance, including in some parts of eastern Africa.

4 May 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
ALAudrey Lacroix
Audrey Lacroix
PKPlacide Mbala Kingebeni
Placide Mbala Kingebeni
SKSimon Pierre Ndimbo Kumugo
Simon Pierre Ndimbo Kumugo
GLGuy Lempu
Guy Lempu
CBChristelle Butel
Christelle Butel
SMSteve Ahuka Mundeke
Steve Ahuka Mundeke
With 12 of the 31 outbreaks, the Democratic Republic of Congo (DRC) is highly affected by Ebolavirus disease (EVD). To better understand the role of bats in the ecology of Ebola viruses, we conducted surveys in bats during two recent EVD outbreaks and in two areas with previous outbreaks. Dried blood spots were tested for antibodies to ebolaviruses and oral and rectal swabs were screened for the presence of filovirus using a broadly reactive semi-nested RT-PCR. Between 2018 and 2020, 892 (88.6%) frugivorous and 115 (11.4%) insectivorous bats were collected. Overall, 11/925 (1.2%) to 100/925 (10.8%) bats showed antibodies to at least one Ebolavirus antigen depending on the positivity criteria. Antibodies were detected in fruit bats from the four sites and from species previously documented to harbor Ebola antibodies or RNA. We tested for the first time a large number of bats during ongoing EVD outbreaks in DRC, but no viral RNA was detected in the 676 sampled bats. Our study illustrates the difficulty to document the role of bats as a source of Ebolaviruses as they might clear quickly the virus. Given the increasing frequency of EVD outbreaks, more studies on the animal reservoir are urgently needed.

14 March 2022 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
DMDaniel Mukadi-Bamuleka
Daniel Mukadi-Bamuleka
JBJunior Bulabula-Penge
Junior Bulabula-Penge
AWAnja De Weggheleire
Anja De Weggheleire
BJBart K M Jacobs
Bart K M Jacobs
FEFrançois Edidi-Atani
François Edidi-Atani
SASteve Ahuka-Mundeke
Steve Ahuka-Mundeke

23 January 2024 in The Lancet Microbe
Verified
Journal Article
Open access
EKEddy Kinganda-Lusamaki
Eddy Kinganda-Lusamaki
SWShannon Whitmer
Shannon Whitmer
ELEmmanuel Lokilo-Lofiko
Emmanuel Lokilo-Lofiko
AAAdrienne Amuri-Aziza
Adrienne Amuri-Aziza
FMFrancisca Muyembe-Mawete
Francisca Muyembe-Mawete
PMPlacide Kingebeni Mbala
Placide Kingebeni Mbala
The Democratic Republic of the Congo has had 15 Ebola virus disease (EVD) outbreaks, from 1976 to 2023. On June 1, 2020, the Democratic Republic of the Congo declared an outbreak of EVD in the western Équateur Province (11th outbreak), proximal to the 2018 Tumba and Bikoro outbreak and concurrent with an outbreak in the eastern Nord Kivu Province. In this Article, we assessed whether the 11th outbreak was genetically related to previous or concurrent EVD outbreaks and connected available epidemiological and genetic data to identify sources of possible zoonotic spillover, uncover additional unreported cases of nosocomial transmission, and provide a deeper investigation into the 11th outbreak. We analysed epidemiological factors from the 11th EVD outbreak to identify patient characteristics, epidemiological links, and transmission modes to explore virus spread through space, time, and age groups in the Équateur Province, Democratic Republic of the Congo. Trained field investigators and health professionals recorded data on suspected, probable, and confirmed cases, including demographic characteristics, possible exposures, symptom onset and signs and symptoms, and potentially exposed contacts. We used blood samples from individuals who were live suspected cases and oral swabs from individuals who were deceased to diagnose EVD. We applied whole-genome sequencing of 87 available Ebola virus genomes (from 130 individuals with EVD between May 19 and Sept 16, 2020), phylogenetic divergence versus time, and Bayesian reconstruction of phylogenetic trees to calculate viral substitution rates and study viral evolution. We linked the available epidemiological and genetic datasets to conduct a genomic and epidemiological study of the 11th EVD outbreak. Between May 19 and Sept 16, 2020, 130 EVD (119 confirmed and 11 probable) cases were reported across 13 Équateur Province health zones. The individual identified as the index case reported frequent consumption of bat meat, suggesting the outbreak started due to zoonotic spillover. Sequencing revealed two circulating Ebola virus variants associated with this outbreak-a Mbandaka variant associated with the majority (97%) of cases and a Tumba-like variant with similarity to the ninth EVD outbreak in 2018. The Tumba-like variant exhibited a reduced substitution rate, suggesting transmission from a previous survivor of EVD. Integrating genetic and epidemiological data allowed for investigative fact-checking and verified patient-reported sources of possible zoonotic spillover. These results demonstrate that rapid genetic sequencing combined with epidemiological data can inform responders of the mechanisms of viral spread, uncover novel transmission modes, and provide a deeper understanding of the outbreak, which is ultimately needed for infection prevention and control during outbreaks. WHO and US Centers for Disease Control and Prevention.

1 January 2023 in Emerging Infectious Diseases
Verified
Journal Article
Open access
PDF file
DMDaniel Mukadi-Bamuleka
Daniel Mukadi-Bamuleka
FMFabrice Mambu-Mbika
Fabrice Mambu-Mbika
AWAnja De Weggheleire
Anja De Weggheleire
FEFrançois Edidi-Atani
François Edidi-Atani
JBJunior Bulabula-Penge
Junior Bulabula-Penge
SASteve Ahuka-Mundeke
Steve Ahuka-Mundeke
Field Laboratories during Chronic Insecurity, DRC